STAAR SURGICAL CO (STAA) Forecast, Price Target & Analyst Ratings
NASDAQ:STAA • US8523123052
19.22 USD
+0.3 (+1.59%)
At close: Mar 4, 2026
19.22 USD
0 (0%)
After Hours: 3/4/2026, 8:00:01 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for STAAR SURGICAL CO (STAA).
Forecast Snapshot
Consensus Price Target
$23.15
+ 20.44% Upside
Next Earnings Forecast
Release DateN/A
PeriodQ1 / 2026
EPS Estimate-$0.08
Revenue Estimate71.732M
ChartMill Buy Consensus
52.50%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$23.15
Upside
+ 20.44%
From current price of $19.22 to mean target of $23.15, Based on 16 analyst forecasts
Low
$13.13
Median
$22.44
High
$32.29
Price Target Revisions
1 Month
-10.34%
3 Months
-7.84%
Price Target Summary
16 analysts have analysed STAA and the average price target is 23.15 USD. This implies a price increase of 20.44% is expected in the next year compared to the current price of 19.22.
The average price target has been revised downward by 7.84% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
52.50%
STAA was analyzed by 16 analysts. The buy percentage consensus is at 53. So analysts seem to be rather neutral about STAA.
In the previous month the buy percentage consensus was at a similar level.
STAA was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-04 | Stifel | Maintains | Hold -> Hold |
| 2026-02-09 | Stifel | Maintains | Hold -> Hold |
| 2026-02-03 | Wedbush | Initiate | Neutral |
| 2026-01-28 | Jefferies | Maintains | Buy -> Buy |
| 2026-01-16 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-12-10 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-12-10 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-08-07 | Stifel | Downgrade | Buy -> Hold |
| 2025-08-06 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-08-05 | Sidoti & Co. | Downgrade | Buy -> Neutral |
| 2025-07-16 | Mizuho | Maintains | Neutral -> Neutral |
| 2025-05-27 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-05-21 | Needham | Reiterate | Hold -> Hold |
| 2025-05-08 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-04-21 | Wells Fargo | Initiate | Equal-Weight |
| 2025-03-18 | Stephens & Co. | Reiterate | Equal-Weight -> Equal-Weight |
| 2025-02-27 | Needham | Reiterate | Hold -> Hold |
| 2025-02-13 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-02-12 | William Blair | Downgrade | Outperform -> Market Perform |
| 2025-02-12 | Needham | Reiterate | Hold -> Hold |
| 2025-02-12 | Stephens & Co. | Reiterate | Equal-Weight -> Equal-Weight |
| 2025-02-12 | Stifel | Maintains | Buy -> Buy |
| 2025-02-12 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-01-07 | Needham | Reiterate | Hold -> Hold |
| 2024-12-09 | Canaccord Genuity | Maintains | Hold -> Hold |
Next Earnings Forecast Details
Next Earnings Details
Release DateN/A
PeriodQ1 / 2026
EPS Estimate-$0.08
Revenue Estimate71.732M
Revenue Q2Q68.43%
EPS Q2Q84.22%
Number of Analysts11
Next Earnings Revisions
Revenue (1 Month)
-0.71%
Revenue (3 Months)
-2.01%
EPS (1 Month)
-13.42%
EPS (3 Months)
2.04%
Next Earnings Summary
The next earnings revenue estimate has been revised downward by 2.01% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 284.4M 23.38% | 322.415M 13.37% | 313.901M -2.64% | 262.67M -16.32% | 320.45M 22.00% | 346.6M 8.16% | 376.02M 8.49% | 433.5M 15.29% | 491.64M 13.41% | 539.58M 9.75% | |
| EBITDA YoY % growth | 48.31M 30.78% | 33.221M -31.23% | -4.026M -112.12% | 6.939M 272.35% | 37.065M 434.15% | 51.639M 39.32% | 60.384M 16.93% | 101.95M 68.84% | 89.76M -11.96% | 99.96M 11.36% | |
| EBIT YoY % growth | 43.8M 31.53% | 28.097M -35.85% | -10.917M -138.85% | -68.788M -530.10% | 3.623M 105.27% | 13.985M 286.01% | 21.562M 54.18% | 66.249M 207.25% | 73.44M 10.85% | 83.64M 13.89% | |
| Operating Margin | 15.40% | 8.71% | -3.48% | -26.19% | 1.13% | 4.03% | 5.73% | 15.28% | 14.94% | 15.50% | |
| EPS YoY % growth | 0.78 59.18% | 0.60 -23.08% | 0.33 -45.00% | -1.09 -296.97% | 0.14 121.74% | 0.63 346.39% | 0.58 -7.85% | 1.35 131.58% | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.08 84.22% | 0.07 120.25% | 0.08 -56.08% | -0.01 -112.75% |
| Revenue Q2Q % growth | 71.732M 68.43% | 86.306M 94.73% | 80.161M -15.38% | 70.667M 22.26% |
| EBITDA Q2Q % growth | 5.566M 117.18% | 11.397M 155.86% | 12.542M -59.22% | 6.849M -50.36% |
| EBIT Q2Q % growth | -5.14M 85.20% | 2.285M 109.25% | 3.26M -86.66% | -2.977M -231.48% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
42.51%
EPS Next 5 Year
42.05%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
12.70%
Revenue Next 5 Year
13.36%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
94.95%
EBIT Next 5 Year
71.01%
STAAR SURGICAL CO / STAA Forecast FAQ
Can you provide the average price target for STAAR SURGICAL CO stock?
16 analysts have analysed STAA and the average price target is 23.15 USD. This implies a price increase of 20.44% is expected in the next year compared to the current price of 19.22.
Can you provide the consensus estimates for STAAR SURGICAL CO next earnings?
The consensus EPS estimate for the next earnings of STAAR SURGICAL CO (STAA) is -0.08 USD and the consensus revenue estimate is 71.73M USD.
Can you provide the expected long term growth rate for STAAR SURGICAL CO stock?
The expected long term growth rate for STAAR SURGICAL CO (STAA) is 12.7%.